Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (11008)	11/18/1998 11:50:00 AM
From: bucko	Respond to of 14328

Tuesday November 17 5:37 PM ET 170,000 at-home HIV tests performed NEW YORK, Nov 17 (Reuters Health) -- More than 170,000 HIV tests were conducted using home sample collection kits in 1996 and 1997, accounting for 1% of the 16.6 million HIV tests conducted every year in the US. And despite initial fears about receiving HIV results over the phone, it appears that such products help reach people who would not normally be tested at a doctor's office or public clinic, according to the report in the November 18th issue of The Journal of the American Medical Association. The kits, which cost $30 to $40, were used by people in every state in America, as well as the District of Columbia, Puerto Rico and the US Virgin Islands, according to data supplied by the two manufacturers of the tests, Home Access Health Corporation of Hoffman Estates, Illinois, and Direct Access Diagnostics of Bridgewater, New Jersey. A kit-user pricks his or her finger and places a spot of blood on filter paper, which is then mailed to the company with an identifying number. The person calls in for the test results, using only the number as an identifier to maintain confidentiality. Of the 174,316 tests performed in the first year after the kits were approved by the US Food and Drug Administration, 0.9% were positive for HIV. ''Most users were heterosexual; the largest percentages were men, white and aged 25 to 34 years,'' reported Dr. Bernard Branson, of the National Center for HIV, STD and TB Prevention at the Centers for Disease Control and Prevention in Atlanta, Georgia. ''The HIV prevalence was highest among African-Americans and Hispanics, those aged 35 to 44 years, men who have sex with men and injection drug users.'' As for receiving the test results over the phone, 7% of the people said they were shocked and dismayed by the unexpected result, 5% hung up immediately without getting counseling or referrals, and one person said they were contemplating suicide. However, the counselor ''noted that this person was with a friend, who agreed to facilitate mental health support,'' according to the report. ''Home sample collection tests for HIV were used by persons who were at risk for HIV and by persons who did not use other testing,'' Branson concluded. ''Most HIV-positive users either had a source of medical care or received referrals.'' SOURCE: The Journal of the American Medical Association 1998;280:1699-1701.

To: Scott H. Davis who wrote (11008)	11/19/1998 9:02:00 AM
From: AgAuUSA	Read Replies (2) \| Respond to of 14328

OK, Scott here's some feedback from a techy. Maybe you know him? I know you are less than positive to somewhat negative on Triby. I and afew others are of differing opinion: www3.techstocks.com Thursday, Nov 19 1998 1:54AM ET Reply # of 23195 David, The TRIBY chart sure has that poised for take-off shape to it. It's the same look that POSS, AMSWA and OXGN had just before their moves. AMSWA gave it all back but there was a bunch of profit to be had while it lasted. Yep, TRIBY should at least attempt a sizable move. Doug R